Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: ?
Life Threatening? No
Write-up: A.R.D.S.; COVID-19; COVID-19; Dyspnoea; Shivering; Coughing; Fever; peripheral circulatory failure; exhaustion; Groggy; This is a spontaneous report from a non-contactable physician downloaded from the regulatory authority-WEB, regulatory authority number DE-PEI-202100032679. A 61-year-old male patient received bnt162b2 (COMIRNATY), via an unspecified route of administration on 06Jan2021 (Batch/Lot Number: EJ6797) as 0.3 mL, single for COVID -19 immunization. Medical history included ongoing Arterial hypertension. The patient''s concomitant medications were not reported. The patient experienced shivering, fever, exhaustion, groggy, coughing, peripheral circulatory failure on 07Jan2021, Dyspnoea and COVID-19 on 11Jan2021 (both hospitalization), experienced ARDS on 02Feb2021 (hospitalization). The patient died on 02Feb2021 caused by ARDS. An autopsy was not performed. The event outcome was not recovered for shivering, fever, exhaustion, groggy, coughing, peripheral circulatory failure, dyspnoea, COVID-19, fatal for ARDS. No follow-up attempts possible. No further information expected. Information on lot# already obtained.; Reported Cause(s) of Death: ARDS
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166